Exploring the impact of the national tender system on the use of costly drugs treating rheumatoid arthritis patients in ten rheumatology centers in Norway (2010–2019)

BACKGROUND: Biologic and targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) are highly effective in treating rheumatoid arthritis (RA), albeit high drug cost has restricted their use in many countries. As a countermeasure, Norway implemented pharmaceutical tendering as a cost-redu...

Descripción completa

Detalles Bibliográficos
Autores principales: Brkic, Alen, Diamantopoulos, Andreas P, Hoff, Mari, Haavardsholm, Espen Andre, Fevang, Bjørg Tilde Svanes, Brekke, Lene Kristin, Loli, Liz, Zettel, Camilla, Bakland, Gunnstein, Mielnik, Pawel, Haugeberg, Glenn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486045/
https://www.ncbi.nlm.nih.gov/pubmed/37679747
http://dx.doi.org/10.1186/s12913-023-09975-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486045/
https://www.ncbi.nlm.nih.gov/pubmed/37679747
http://dx.doi.org/10.1186/s12913-023-09975-7

Ejemplares similares